Lumov  founded by Saumaric Dangwal and Ankit Gupta  has secured a seed-round funding of ₹ 10 crore (US$ 1.2 million), led by Incubate Fund Asia, with additional backing from QRG Investments & Holdings (Havells family office), IIMA Ventures, SIDBI and a group of angel investors including leaders from Helion, Steinberg India and other investor families. 

Lumov develops orthopedic recovery and rehabilitation products  including braces, orthoses, and mobility-support aids that cater to post-surgical care, chronic pain management and long-term mobility support. The products are designed in collaboration with orthopaedic specialists from leading hospital networks such as Manipal Hospitals, Apollo Hospitals, Sakra and AIG, ensuring clinical validation and suitability for Indian patients’ needs. 

With the fresh capital, Lumov intends to expand its manufacturing base and increase production capacity, build out its distribution network into major cities (Delhi NCR, Hyderabad and Mumbai), and ramp up hiring across product development, sales, and operations. Its current core team of about 15 is expected to grow significantly.

Investors and company leadership highlight a widening demand in India’s musculoskeletal (MSK) care  driven by growing surgical volumes, rising lifestyle-linked orthopedic problems, and an under-served rehabilitation/rehab-aid ecosystem. Lumov’s “surgeon-led, India-first, clinically-designed orthoses” approach aims to fill a gap between low-quality mass-market braces and expensive imported rehab aids.